ENDRA Life Sciences
NDRA
5 hedge funds and large institutions have $278K invested in ENDRA Life Sciences in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 1 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 1
78% more capital invested
Capital invested by funds: $156K → $278K (+$122K)
0% more funds holding
Funds holding: 5 → 5 (0)
0% less ownership
Funds ownership: 0% → 0% (-0%)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$4.21K |
| 2 |
JP Morgan Chase
New York
|
+$4.21K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.1K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$11K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
-$4.21K |
NDRA Hedge Fund Activity: Q4 2023 in Review
5 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in ENDRA Life Sciences (NDRA) for Q4 2023, worth a combined $278K — up 78% from $156K a quarter earlier.
Fund positioning in NDRA was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 2 added to existing stakes and 1 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $4.21K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $11K sold.
- 5 institutional investors held ENDRA Life Sciences (NDRA) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $278K of ENDRA Life Sciences stock for Q4 2023, up 78% quarter-over-quarter.
- 1 fund opened new ENDRA Life Sciences positions in Q4 2023 and 1 closed out, a net change of 0 holders.
- The largest ENDRA Life Sciences buyer in Q4 2023 was Geode Capital Management, an estimated $4.21K added.
- The largest ENDRA Life Sciences seller in Q4 2023 was Renaissance Technologies, an estimated $11K sold.
Based on aggregated 13F filings for Q4 2023.